23/10/2025
Laurus Labs reports strong H1 FY26 results! Revenue ₹3,223 Cr, EBITDA ₹818 Cr, and Net Profit ₹390 Cr! CDMO and Generics drive growth
Laurus Labs is a leading research-driven pharmaceutical and biotechnology company.
Road No. 1, Plot No. 103, Jubilee Hills
Hyderabad
500033
| Monday | 9am - 6pm |
| Tuesday | 9am - 6pm |
| Wednesday | 9am - 6pm |
| Thursday | 9am - 6pm |
| Friday | 9am - 6pm |
| Saturday | 9am - 6pm |
Be the first to know and let us send you an email when Laurus Labs Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Laurus Labs Limited: